Results 221 to 230 of about 33,525 (299)
Abstract The macaúba fruit, native to tropical and subtropical regions, has received considerable attention in recent years as a promising raw material for the production of advanced biofuels in Brazil. However, the development of large‐scale biomass requires overcoming significant challenges, such as designing circular biorefineries.
Fábio de A. Oroski +3 more
wiley +1 more source
Hair Products Marketed to Adolescents on Social Media: A Cross-Sectional Study. [PDF]
Chalupczak NV, Iorizzo M, Lipner SR.
europepmc +1 more source
Abstract This study hypothesizes that cashew apple bagasse‐based anaerobic digestion, combined with biochar purification, enhances biogas quality and sustainability. This study aims to investigate the performance and sustainability of a biochar‐based biogas purification technology using cashew apple bagasse as a substrate, with a focus on environmental
Priscila Marchiori +5 more
wiley +1 more source
Occupational airborne exposures and asthma mortality - examining asthma as the underlying and contributing cause of death. [PDF]
Torén K +4 more
europepmc +1 more source
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
Alarmins differentially modulate airway contraction and relaxation of human small airways. [PDF]
Kennedy JL +3 more
europepmc +1 more source
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz +7 more
wiley +1 more source
Assessment of Lifetime Inhalational Exposure Burden and Associations With Chronic Rhinosinusitis. [PDF]
Westcott NM +13 more
europepmc +1 more source
Safety and pharmacokinetics of inhaled aloxistatin: A first‐in‐human phase 1 dose escalation trial
Aims Aloxistatin (E64d) is a membrane‐permeable cysteine protease inhibitor prodrug that is converted by esterases to the active metabolite E64c (loxistatin). This first‐in‐human study evaluated the safety, tolerability and pharmacokinetics of single ascending doses of inhaled E64d in healthy volunteers.
Sebastian Fähndrich +24 more
wiley +1 more source
Recurrent laryngeal leukoplakia in a cook occupationally exposed to cooking oil fumes: a case report. [PDF]
Lee KE, Ma SW, Kwon J, Lee YS, Ye S.
europepmc +1 more source

